JoVE Logo

サインイン

6.20 : Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.

One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential toxicity. Monitoring renal function is crucial in adjusting dosage regimens appropriately to avoid adverse drug reactions.

Examining renal function involves measuring the glomerular filtration rate (GFR). Several markers are used clinically to assess GFR, including inulin, serum creatinine, and Cystatin C levels. Inulin, a substance entirely excreted by glomerular filtration, provides a reliable reference for GFR measurement. At the same time, Cystatin C, a protein produced by all nucleated cells, is inversely correlated with GFR and serves as an additional marker for renal function assessment.

Serum creatinine levels are also commonly used as an indicator of renal function. Creatinine is a waste product generated by muscle metabolism that is excreted by the kidneys. However, it is important to note that creatinine levels may vary depending on age, weight, and gender. So, creatinine clearance is calculated using different formulae considering these factors that account for variations.

Another method for evaluating renal function involves directly measuring the amount of creatinine excreted in urine over 24 hours. By comparing the mean serum creatinine levels before and after the collection period, healthcare professionals can calculate the creatinine clearance.

Creatinine clearance varies based on age, sex, and overall health. For younger, healthy individuals, it typically ranges from 100 to 120 mL/min for males and 90 to 110 mL/min for females. Creatinine clearance also decreases with age, often dropping below 70 mL/min in individuals aged over 65 years.

Renal impairment is categorized into five stages based on the GFR. The most severe level, Stage 5 renal impairment or end-stage renal disease, is characterized by a GFR of less than 15 mL/min and necessitates urgent medical intervention, such as dialysis. These stages help assess the level of renal dysfunction and guide decisions regarding drug dosage adjustments.

Monitoring and evaluating renal function are essential for patient care, particularly in individuals with renal dysfunction. Healthcare professionals rely on various methods and markers to assess renal function accurately. By understanding the equations and measurements in evaluating renal function, clinicians can make informed decisions to optimize drug therapy and minimize the risk of adverse events.

タグ

Renal ClearanceRenal ImpairmentRenal DysfunctionDrug TherapyUremiaGlomerular Filtration Rate GFRCreatinine LevelsCystatin CCreatinine ClearanceDrug AccumulationToxicityDosage AdjustmentsEnd stage Renal DiseaseDialysisSerum Creatinine

章から 6:

article

Now Playing

6.20 : Factors Affecting Renal Clearance: Renal Impairment

Pharmacokinetics: Drug Excretion and Clearance

50 閲覧数

article

6.1 : Drug Elimination: Overview

Pharmacokinetics: Drug Excretion and Clearance

986 閲覧数

article

6.2 : Elimination Kinetics: First-Order and Zero-Order

Pharmacokinetics: Drug Excretion and Clearance

401 閲覧数

article

6.3 : Renal Drug Excretion: Overview

Pharmacokinetics: Drug Excretion and Clearance

100 閲覧数

article

6.4 : Renal Drug Excretion: Glomerular Filtration

Pharmacokinetics: Drug Excretion and Clearance

135 閲覧数

article

6.5 : Renal Drug Excretion: Tubular Reabsorption

Pharmacokinetics: Drug Excretion and Clearance

88 閲覧数

article

6.6 : Renal Drug Excretion: Tubular Secretion

Pharmacokinetics: Drug Excretion and Clearance

116 閲覧数

article

6.7 : Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Pharmacokinetics: Drug Excretion and Clearance

132 閲覧数

article

6.8 : Hepatic Drug Excretion: Enterohepatic Cycling

Pharmacokinetics: Drug Excretion and Clearance

963 閲覧数

article

6.9 : Hepatic Drug Excretion: Influencing Factors

Pharmacokinetics: Drug Excretion and Clearance

79 閲覧数

article

6.10 : Drug Excretion: Pulmonary and Glandular Routes

Pharmacokinetics: Drug Excretion and Clearance

66 閲覧数

article

6.11 : Drug Excretion: Miscellaneous Routes

Pharmacokinetics: Drug Excretion and Clearance

34 閲覧数

article

6.12 : Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

46 閲覧数

article

6.13 : Clearance Models: Physiological Models

Pharmacokinetics: Drug Excretion and Clearance

45 閲覧数

article

6.14 : Clearance Models: Compartment Models

Pharmacokinetics: Drug Excretion and Clearance

47 閲覧数

See More

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved